Advancements in Programmable Lipid Nanoparticles: Exploring the Four-Domain Model for Targeted Drug Delivery
Programmable lipid nanoparticles, or LNPs, represent a breakthrough in the realm of targeted drug delivery, offering precise spatiotemporal control essential for the treatment of complex diseases such as cancer and genetic disorders. In order to provide a more modular perspective and a more balanced analysis of the mechanism, this review presents a novel Four-Domain Model that consists of Architecture, Interface, Payload, and Dispersal Domain. We explored the dynamical equilibrium between LNPs components and the surroundings throughout their destiny, from formulation to release. On the basis of this, we delve deep into manufacturing challenges, scalability issues, and regulatory hurdles, associated with the clinical translation of LNP technology. Within the framework focusing on the programmability in each domain, we prioritized patient-centric factors like dosing regimens, administration techniques, and potential consequences. Notably, this review expands to innovative anatomical routes, such as intranasal and intraocular administration, offering a thorough examination of the advantages and disadvantages of each route. We also offered a comprehensive comparison between artificial LNPs and natural exosomes in terms of functionality, biocompatibility, and therapeutic potential. Ultimately, this review highlights the potential of programmable LNPs to evolve into more intelligent, naturally integrated systems, achieving optimal biocompatibility and functionality.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Generative Model for Synthesizing Ionizable Lipids: A Monte Carlo Tree Search Approach
Ionizable lipids are essential in developing lipid nanoparticles (LNPs) for effective messenger RNA (mRNA) delivery. While traditional methods for designing new ionizable lipids are typically time-consuming, deep generat…
A differentiable machine learning small-angle X-ray scattering analysis framework for structure elucidation of lipid nanoparticles
Lipid nanoparticles (LNPs) are efficient delivery systems for negatively charged nucleic acids. Their multi-component architecture yields a core-shell structure. Small-angle X-ray scattering (SAXS) is an important charac…
A Deep Generative Model for the Design of Synthesizable Ionizable Lipids
Lipid nanoparticles (LNPs) are vital in modern biomedicine, enabling the effective delivery of mRNA for vaccines and therapies by protecting it from rapid degradation. Among the components of LNPs, ionizable lipids play …
Anionic nanoparticle-lipid membrane interactions: the protonation of anionic ligands at the membrane surface reduces membrane disruption
Monolayer-protected gold nanoparticles (Au NPs) are promising biomedical tools with applications to diagnosis and therapy, thanks to their biocompatibility and versatility. Here we show how the NP surface functionalizati…
LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design
Lipid nanoparticles (LNPs) are among the most clinically mature platforms for nucleic acid delivery, yet designing lipids that are both effective and biologically safe remains a major bottleneck. In practical screening, …